| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Energy Malnutrition | 26 | 2022 | 60 | 5.200 |
Why?
|
| Glutathione | 20 | 2025 | 200 | 3.310 |
Why?
|
| Glycine | 19 | 2025 | 156 | 3.300 |
Why?
|
| Amino Acids | 39 | 2025 | 563 | 3.200 |
Why?
|
| Kwashiorkor | 13 | 2022 | 21 | 3.180 |
Why?
|
| Edema | 13 | 2012 | 129 | 2.640 |
Why?
|
| Arginine | 15 | 2023 | 336 | 2.630 |
Why?
|
| Dietary Supplements | 13 | 2025 | 445 | 2.440 |
Why?
|
| Dietary Proteins | 18 | 2019 | 222 | 2.170 |
Why?
|
| Nitric Oxide | 13 | 2018 | 466 | 2.100 |
Why?
|
| Amino Acids, Branched-Chain | 6 | 2021 | 74 | 1.950 |
Why?
|
| Obesity, Morbid | 3 | 2025 | 231 | 1.910 |
Why?
|
| Leucine | 29 | 2018 | 258 | 1.890 |
Why?
|
| Cysteine | 11 | 2014 | 137 | 1.880 |
Why?
|
| Proteins | 29 | 2011 | 1005 | 1.850 |
Why?
|
| Infant Nutrition Disorders | 6 | 2011 | 15 | 1.680 |
Why?
|
| Glucose | 32 | 2018 | 851 | 1.570 |
Why?
|
| Methionine | 6 | 2023 | 95 | 1.530 |
Why?
|
| Citrulline | 8 | 2023 | 123 | 1.530 |
Why?
|
| Diabetic Ketoacidosis | 3 | 2025 | 168 | 1.460 |
Why?
|
| Bariatric Surgery | 2 | 2024 | 153 | 1.350 |
Why?
|
| Carbon Isotopes | 37 | 2020 | 227 | 1.350 |
Why?
|
| MELAS Syndrome | 5 | 2017 | 34 | 1.330 |
Why?
|
| Energy Metabolism | 28 | 2023 | 802 | 1.310 |
Why?
|
| Insulin Resistance | 12 | 2023 | 685 | 1.250 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2025 | 883 | 1.240 |
Why?
|
| Pregnancy | 15 | 2017 | 7396 | 1.200 |
Why?
|
| Malnutrition | 3 | 2022 | 156 | 1.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2025 | 1448 | 1.160 |
Why?
|
| Erythrocytes | 8 | 2014 | 187 | 1.090 |
Why?
|
| Glutamine | 14 | 2023 | 201 | 0.990 |
Why?
|
| Alanine | 21 | 2014 | 159 | 0.950 |
Why?
|
| Kinetics | 35 | 2019 | 1085 | 0.920 |
Why?
|
| Adult | 76 | 2025 | 31042 | 0.860 |
Why?
|
| Hyperglycemia | 4 | 2025 | 233 | 0.850 |
Why?
|
| Acute-Phase Proteins | 8 | 2004 | 45 | 0.850 |
Why?
|
| Child Nutrition Disorders | 3 | 2012 | 41 | 0.850 |
Why?
|
| Gluconeogenesis | 14 | 2014 | 93 | 0.840 |
Why?
|
| Benzoic Acid | 1 | 2024 | 4 | 0.840 |
Why?
|
| Oxidation-Reduction | 23 | 2020 | 434 | 0.830 |
Why?
|
| Energy Intake | 8 | 2017 | 502 | 0.820 |
Why?
|
| Humans | 163 | 2025 | 130154 | 0.800 |
Why?
|
| Burns | 18 | 2000 | 92 | 0.800 |
Why?
|
| Tryptophan | 2 | 2022 | 83 | 0.790 |
Why?
|
| Body Mass Index | 9 | 2018 | 1685 | 0.780 |
Why?
|
| Thinness | 2 | 2016 | 71 | 0.760 |
Why?
|
| Shock, Septic | 3 | 2009 | 149 | 0.750 |
Why?
|
| Kynurenine | 1 | 2022 | 24 | 0.750 |
Why?
|
| Female | 101 | 2025 | 70285 | 0.750 |
Why?
|
| Blood Proteins | 10 | 2014 | 143 | 0.750 |
Why?
|
| Liver | 28 | 2018 | 1788 | 0.730 |
Why?
|
| Pregnancy Outcome | 3 | 2016 | 614 | 0.690 |
Why?
|
| Male | 104 | 2025 | 64397 | 0.690 |
Why?
|
| Nitrogen | 14 | 2011 | 120 | 0.680 |
Why?
|
| Fatty Acids, Nonesterified | 9 | 2018 | 112 | 0.680 |
Why?
|
| Urea | 20 | 2011 | 219 | 0.680 |
Why?
|
| Carnitine | 1 | 2021 | 70 | 0.660 |
Why?
|
| Amino Acids, Aromatic | 2 | 2014 | 3 | 0.640 |
Why?
|
| Case-Control Studies | 16 | 2025 | 3350 | 0.630 |
Why?
|
| Protein Biosynthesis | 16 | 2014 | 571 | 0.630 |
Why?
|
| Growth Disorders | 3 | 2023 | 182 | 0.630 |
Why?
|
| Weight Gain | 8 | 2018 | 384 | 0.630 |
Why?
|
| India | 9 | 2019 | 231 | 0.620 |
Why?
|
| Gastrectomy | 1 | 2020 | 104 | 0.620 |
Why?
|
| Insulin | 28 | 2024 | 1143 | 0.620 |
Why?
|
| Blood Glucose | 25 | 2018 | 1108 | 0.600 |
Why?
|
| Nutritional Requirements | 6 | 2015 | 160 | 0.590 |
Why?
|
| Models, Biological | 7 | 2016 | 1376 | 0.580 |
Why?
|
| Sepsis | 6 | 2013 | 496 | 0.580 |
Why?
|
| Isotope Labeling | 16 | 2020 | 95 | 0.560 |
Why?
|
| Acetylcysteine | 4 | 2023 | 79 | 0.550 |
Why?
|
| Phenylalanine | 13 | 2023 | 131 | 0.540 |
Why?
|
| Body Composition | 9 | 2015 | 541 | 0.530 |
Why?
|
| Body Weight | 10 | 2023 | 985 | 0.530 |
Why?
|
| Apolipoprotein B-100 | 8 | 2012 | 36 | 0.530 |
Why?
|
| Tyrosine | 7 | 2011 | 142 | 0.520 |
Why?
|
| Oxidative Stress | 4 | 2023 | 793 | 0.520 |
Why?
|
| Pregnancy in Adolescence | 2 | 2014 | 54 | 0.510 |
Why?
|
| Pregnancy Trimester, First | 6 | 2016 | 115 | 0.500 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2017 | 48 | 0.490 |
Why?
|
| Amino Acids, Sulfur | 3 | 2012 | 14 | 0.490 |
Why?
|
| Nitrogen Isotopes | 12 | 2015 | 45 | 0.480 |
Why?
|
| Carbon Dioxide | 9 | 2009 | 269 | 0.480 |
Why?
|
| Isotopes | 5 | 2019 | 24 | 0.470 |
Why?
|
| Lipid Metabolism | 10 | 2018 | 371 | 0.460 |
Why?
|
| Diet | 10 | 2019 | 1097 | 0.460 |
Why?
|
| Lipolysis | 10 | 2010 | 77 | 0.460 |
Why?
|
| Infant | 25 | 2022 | 13276 | 0.450 |
Why?
|
| Serine | 2 | 2016 | 161 | 0.450 |
Why?
|
| Birth Weight | 3 | 2016 | 345 | 0.450 |
Why?
|
| Diet, Protein-Restricted | 6 | 2019 | 71 | 0.450 |
Why?
|
| Aging | 5 | 2023 | 1236 | 0.420 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 645 | 0.420 |
Why?
|
| Food Quality | 1 | 2014 | 4 | 0.420 |
Why?
|
| Glucagon | 17 | 2004 | 145 | 0.410 |
Why?
|
| Pyruvic Acid | 3 | 2011 | 35 | 0.410 |
Why?
|
| Deuterium | 11 | 2015 | 95 | 0.410 |
Why?
|
| Insulin-Secreting Cells | 3 | 2024 | 133 | 0.400 |
Why?
|
| Middle Aged | 34 | 2025 | 28331 | 0.400 |
Why?
|
| Protein Deficiency | 4 | 1999 | 19 | 0.390 |
Why?
|
| Fabaceae | 2 | 2023 | 17 | 0.390 |
Why?
|
| Autoantibodies | 3 | 2024 | 436 | 0.390 |
Why?
|
| Apolipoproteins B | 8 | 2006 | 142 | 0.390 |
Why?
|
| Methylation | 5 | 2017 | 198 | 0.390 |
Why?
|
| Lactates | 9 | 2004 | 81 | 0.380 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 542 | 0.380 |
Why?
|
| Dichloroacetic Acid | 7 | 2004 | 11 | 0.380 |
Why?
|
| Enterocytes | 1 | 2013 | 68 | 0.380 |
Why?
|
| Intestinal Mucosa | 12 | 2013 | 763 | 0.380 |
Why?
|
| Muscle Proteins | 6 | 2005 | 401 | 0.370 |
Why?
|
| Lipoproteins, VLDL | 1 | 2012 | 53 | 0.360 |
Why?
|
| Severity of Illness Index | 5 | 2014 | 3025 | 0.360 |
Why?
|
| Reference Values | 14 | 2010 | 674 | 0.350 |
Why?
|
| Fatty Liver | 3 | 2018 | 218 | 0.350 |
Why?
|
| Dietary Carbohydrates | 3 | 2009 | 105 | 0.350 |
Why?
|
| Metabolomics | 4 | 2025 | 501 | 0.340 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 5 | 2012 | 25 | 0.340 |
Why?
|
| Animals, Newborn | 11 | 2008 | 1018 | 0.340 |
Why?
|
| Rest | 1 | 2011 | 64 | 0.330 |
Why?
|
| Mitochondria | 5 | 2023 | 768 | 0.310 |
Why?
|
| Liver Cirrhosis | 3 | 2004 | 902 | 0.310 |
Why?
|
| Glycerol | 5 | 2010 | 78 | 0.310 |
Why?
|
| Stress, Physiological | 5 | 1995 | 257 | 0.310 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 140 | 0.300 |
Why?
|
| Glutamic Acid | 8 | 2000 | 192 | 0.300 |
Why?
|
| Pregnancy Trimesters | 3 | 2016 | 34 | 0.300 |
Why?
|
| HIV Infections | 8 | 2013 | 2040 | 0.300 |
Why?
|
| Infant, Low Birth Weight | 4 | 2016 | 169 | 0.300 |
Why?
|
| Carbon | 3 | 2022 | 100 | 0.300 |
Why?
|
| Muscle, Skeletal | 7 | 2013 | 979 | 0.300 |
Why?
|
| Adolescent | 22 | 2024 | 20802 | 0.290 |
Why?
|
| Feeding Behavior | 2 | 2013 | 708 | 0.290 |
Why?
|
| Splanchnic Circulation | 3 | 2013 | 49 | 0.290 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2016 | 122 | 0.280 |
Why?
|
| Homeostasis | 7 | 2009 | 712 | 0.280 |
Why?
|
| Inflammation | 4 | 2023 | 1481 | 0.280 |
Why?
|
| Apolipoprotein A-I | 6 | 2007 | 80 | 0.280 |
Why?
|
| Fibrinogen | 9 | 2004 | 170 | 0.270 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 9 | 2005 | 63 | 0.270 |
Why?
|
| Homocysteine | 3 | 2017 | 116 | 0.270 |
Why?
|
| Swine | 21 | 2008 | 1184 | 0.270 |
Why?
|
| Child | 24 | 2024 | 26181 | 0.270 |
Why?
|
| Fetal Growth Retardation | 1 | 2010 | 254 | 0.270 |
Why?
|
| Digestion | 3 | 2023 | 42 | 0.270 |
Why?
|
| Prealbumin | 5 | 2007 | 27 | 0.260 |
Why?
|
| Anemia, Sickle Cell | 3 | 2006 | 333 | 0.260 |
Why?
|
| C-Peptide | 2 | 2024 | 105 | 0.260 |
Why?
|
| Infusions, Intravenous | 10 | 2011 | 533 | 0.260 |
Why?
|
| Retinol-Binding Proteins | 4 | 2004 | 21 | 0.250 |
Why?
|
| Biomarkers | 3 | 2025 | 3360 | 0.240 |
Why?
|
| Rhamnose | 2 | 2023 | 3 | 0.240 |
Why?
|
| Serum Albumin | 9 | 2004 | 101 | 0.240 |
Why?
|
| Overweight | 1 | 2009 | 379 | 0.240 |
Why?
|
| Lactulose | 2 | 2023 | 27 | 0.240 |
Why?
|
| Vigna | 2 | 2023 | 2 | 0.240 |
Why?
|
| Keto Acids | 4 | 2020 | 50 | 0.230 |
Why?
|
| Child, Preschool | 15 | 2023 | 15009 | 0.230 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2010 | 161 | 0.220 |
Why?
|
| Vitamin B 12 | 2 | 2017 | 59 | 0.220 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2017 | 43 | 0.220 |
Why?
|
| Animals | 51 | 2023 | 33698 | 0.220 |
Why?
|
| Hydroxyproline | 1 | 2004 | 7 | 0.210 |
Why?
|
| Young Adult | 10 | 2021 | 9987 | 0.210 |
Why?
|
| Hypotension | 1 | 2006 | 186 | 0.210 |
Why?
|
| Hippurates | 1 | 2024 | 7 | 0.210 |
Why?
|
| Jamaica | 2 | 2015 | 29 | 0.210 |
Why?
|
| Critical Illness | 5 | 2006 | 623 | 0.210 |
Why?
|
| Infant, Newborn | 14 | 2016 | 8551 | 0.210 |
Why?
|
| Parenteral Nutrition, Total | 3 | 2005 | 113 | 0.210 |
Why?
|
| Age Factors | 6 | 2021 | 2823 | 0.200 |
Why?
|
| Muscles | 7 | 1998 | 197 | 0.200 |
Why?
|
| Eating | 8 | 2018 | 375 | 0.200 |
Why?
|
| Intestine, Small | 2 | 2023 | 291 | 0.190 |
Why?
|
| Glycolysis | 3 | 2011 | 174 | 0.180 |
Why?
|
| Transferrin | 3 | 2007 | 46 | 0.180 |
Why?
|
| Acute Disease | 3 | 2014 | 1157 | 0.170 |
Why?
|
| Postpartum Period | 1 | 2003 | 238 | 0.170 |
Why?
|
| Pyruvates | 4 | 1996 | 19 | 0.170 |
Why?
|
| Leg | 3 | 2000 | 119 | 0.170 |
Why?
|
| Indicator Dilution Techniques | 3 | 2015 | 24 | 0.170 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2001 | 19 | 0.170 |
Why?
|
| Hydrocortisone | 5 | 2002 | 213 | 0.160 |
Why?
|
| Gene Products, vpr | 2 | 2013 | 16 | 0.160 |
Why?
|
| Up-Regulation | 3 | 2014 | 824 | 0.160 |
Why?
|
| Liver Transplantation | 2 | 2000 | 1136 | 0.160 |
Why?
|
| Muscle Strength | 1 | 2021 | 76 | 0.160 |
Why?
|
| Glucose Tolerance Test | 4 | 2018 | 198 | 0.160 |
Why?
|
| Epinephrine | 5 | 1994 | 148 | 0.160 |
Why?
|
| Shock, Traumatic | 1 | 2000 | 6 | 0.160 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2019 | 174 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2025 | 1872 | 0.160 |
Why?
|
| Fasting | 9 | 2010 | 304 | 0.150 |
Why?
|
| Anthropometry | 3 | 2013 | 187 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2021 | 322 | 0.150 |
Why?
|
| Acid-Base Equilibrium | 1 | 1999 | 60 | 0.150 |
Why?
|
| Ornithine | 2 | 2018 | 31 | 0.140 |
Why?
|
| Palmitic Acid | 1 | 2018 | 27 | 0.140 |
Why?
|
| Child Development | 1 | 2021 | 267 | 0.140 |
Why?
|
| Gestational Age | 6 | 2013 | 1209 | 0.140 |
Why?
|
| Metabolome | 1 | 2021 | 325 | 0.140 |
Why?
|
| Zea mays | 1 | 2018 | 21 | 0.140 |
Why?
|
| Wounds and Injuries | 4 | 2001 | 389 | 0.140 |
Why?
|
| Hormones | 2 | 2000 | 162 | 0.140 |
Why?
|
| Choline | 1 | 2018 | 48 | 0.140 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 66 | 0.130 |
Why?
|
| Microvessels | 1 | 2018 | 58 | 0.130 |
Why?
|
| Aged | 11 | 2023 | 20833 | 0.130 |
Why?
|
| Diagnostic Techniques, Radioisotope | 1 | 2017 | 1 | 0.130 |
Why?
|
| Albumins | 2 | 1998 | 88 | 0.130 |
Why?
|
| Lactase-Phlorizin Hydrolase | 4 | 1998 | 20 | 0.130 |
Why?
|
| Food Deprivation | 2 | 2008 | 33 | 0.130 |
Why?
|
| Nitrates | 2 | 2007 | 29 | 0.130 |
Why?
|
| Haptoglobins | 4 | 2004 | 9 | 0.130 |
Why?
|
| Bacteria | 1 | 2021 | 524 | 0.130 |
Why?
|
| Nitrites | 2 | 2007 | 48 | 0.130 |
Why?
|
| Tritium | 6 | 1998 | 108 | 0.130 |
Why?
|
| Oocytes | 1 | 2019 | 282 | 0.120 |
Why?
|
| Time Factors | 12 | 2018 | 6178 | 0.120 |
Why?
|
| Folic Acid | 1 | 2019 | 269 | 0.120 |
Why?
|
| Rural Population | 1 | 2019 | 272 | 0.120 |
Why?
|
| Obesity | 3 | 2024 | 2394 | 0.120 |
Why?
|
| Developing Countries | 2 | 2013 | 303 | 0.120 |
Why?
|
| alpha-Glucosidases | 2 | 2009 | 33 | 0.120 |
Why?
|
| Lipodystrophy | 3 | 2004 | 37 | 0.120 |
Why?
|
| Communicable Diseases | 1 | 1998 | 159 | 0.120 |
Why?
|
| Triglycerides | 3 | 2005 | 601 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2021 | 831 | 0.120 |
Why?
|
| Bicarbonates | 3 | 2000 | 98 | 0.120 |
Why?
|
| Cognition | 1 | 2021 | 817 | 0.110 |
Why?
|
| Osmolar Concentration | 3 | 2000 | 147 | 0.110 |
Why?
|
| Breath Tests | 5 | 2009 | 182 | 0.110 |
Why?
|
| HIV-1 | 3 | 2013 | 494 | 0.110 |
Why?
|
| Meals | 1 | 2015 | 59 | 0.110 |
Why?
|
| Ammonia | 6 | 2000 | 67 | 0.110 |
Why?
|
| Radioactive Tracers | 3 | 2011 | 20 | 0.110 |
Why?
|
| RNA, Transfer, Leu | 1 | 2014 | 6 | 0.110 |
Why?
|
| Human Growth Hormone | 2 | 2006 | 73 | 0.110 |
Why?
|
| Postprandial Period | 3 | 2005 | 88 | 0.110 |
Why?
|
| Genes, Mitochondrial | 1 | 2014 | 17 | 0.110 |
Why?
|
| Lipids | 4 | 2012 | 559 | 0.100 |
Why?
|
| C-Reactive Protein | 3 | 2002 | 448 | 0.100 |
Why?
|
| Recommended Dietary Allowances | 1 | 2014 | 21 | 0.100 |
Why?
|
| Infant, Premature | 6 | 2005 | 861 | 0.100 |
Why?
|
| Muscle Fatigue | 1 | 2013 | 6 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Plasma | 5 | 2007 | 16 | 0.100 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2013 | 34 | 0.100 |
Why?
|
| Biological Availability | 2 | 2012 | 136 | 0.100 |
Why?
|
| Hydroxylation | 2 | 2011 | 51 | 0.100 |
Why?
|
| Sulfones | 1 | 2013 | 72 | 0.100 |
Why?
|
| Infant Food | 3 | 2010 | 74 | 0.100 |
Why?
|
| Palmitates | 3 | 2010 | 17 | 0.100 |
Why?
|
| Hemoglobins | 3 | 2006 | 286 | 0.100 |
Why?
|
| Point Mutation | 1 | 2014 | 332 | 0.100 |
Why?
|
| alpha 1-Antitrypsin | 3 | 2007 | 81 | 0.100 |
Why?
|
| Muscle Contraction | 1 | 2013 | 145 | 0.100 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2013 | 104 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3781 | 0.090 |
Why?
|
| Adaptation, Physiological | 4 | 2004 | 259 | 0.090 |
Why?
|
| Fatty Acids | 3 | 2002 | 372 | 0.090 |
Why?
|
| Dogs | 6 | 1999 | 616 | 0.090 |
Why?
|
| Body Fluid Compartments | 2 | 2010 | 18 | 0.090 |
Why?
|
| Jejunum | 3 | 1998 | 123 | 0.090 |
Why?
|
| Piperazines | 1 | 2013 | 269 | 0.090 |
Why?
|
| F2-Isoprostanes | 1 | 2011 | 19 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2013 | 5042 | 0.090 |
Why?
|
| Postoperative Period | 3 | 2001 | 330 | 0.080 |
Why?
|
| Starch | 2 | 2009 | 26 | 0.080 |
Why?
|
| Orosomucoid | 2 | 2002 | 9 | 0.080 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2011 | 42 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2011 | 165 | 0.080 |
Why?
|
| Leptin | 1 | 2012 | 217 | 0.080 |
Why?
|
| Phenylbutyrates | 1 | 2011 | 54 | 0.080 |
Why?
|
| Dietary Fats | 2 | 2005 | 275 | 0.080 |
Why?
|
| Bacterial Infections | 3 | 1991 | 328 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2002 | 410 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2010 | 81 | 0.080 |
Why?
|
| Food | 2 | 1988 | 121 | 0.080 |
Why?
|
| Hormone Replacement Therapy | 1 | 2012 | 180 | 0.080 |
Why?
|
| Hemoglobin SC Disease | 1 | 1989 | 7 | 0.080 |
Why?
|
| Viscera | 2 | 2000 | 56 | 0.080 |
Why?
|
| Acetates | 1 | 1990 | 77 | 0.080 |
Why?
|
| Texas | 2 | 2015 | 3648 | 0.070 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2002 | 150 | 0.070 |
Why?
|
| Food, Formulated | 2 | 2007 | 38 | 0.070 |
Why?
|
| Lysine | 6 | 1998 | 164 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2023 | 1440 | 0.070 |
Why?
|
| Glucagonoma | 2 | 2001 | 3 | 0.070 |
Why?
|
| Glucose Clamp Technique | 5 | 2018 | 75 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2001 | 682 | 0.070 |
Why?
|
| Starvation | 1 | 2007 | 17 | 0.070 |
Why?
|
| Sucrase | 2 | 2009 | 23 | 0.070 |
Why?
|
| Turpentine | 2 | 1999 | 3 | 0.070 |
Why?
|
| Somatostatin | 6 | 2001 | 60 | 0.070 |
Why?
|
| Growth Hormone | 3 | 1992 | 129 | 0.060 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2004 | 52 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 887 | 0.060 |
Why?
|
| Parenteral Nutrition | 3 | 1998 | 219 | 0.060 |
Why?
|
| Microvilli | 4 | 2002 | 62 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 477 | 0.060 |
Why?
|
| Isoprostanes | 1 | 2006 | 4 | 0.060 |
Why?
|
| Glutathione Disulfide | 1 | 2006 | 19 | 0.060 |
Why?
|
| Metabolism, Inborn Errors | 3 | 2004 | 125 | 0.060 |
Why?
|
| Leukocyte Count | 1 | 2006 | 246 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 783 | 0.060 |
Why?
|
| Enteral Nutrition | 3 | 2004 | 286 | 0.060 |
Why?
|
| Antioxidants | 1 | 2008 | 334 | 0.060 |
Why?
|
| Radioisotope Dilution Technique | 4 | 1997 | 37 | 0.060 |
Why?
|
| Hindlimb | 3 | 2008 | 72 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 116 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 526 | 0.060 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2004 | 85 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2000 | 2079 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 423 | 0.050 |
Why?
|
| Amino Acids, Essential | 2 | 2019 | 21 | 0.050 |
Why?
|
| Creatinine | 2 | 2006 | 396 | 0.050 |
Why?
|
| Body Water | 1 | 2004 | 87 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2010 | 256 | 0.050 |
Why?
|
| Enzymes | 1 | 2004 | 44 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2016 | 12843 | 0.050 |
Why?
|
| Animal Feed | 2 | 2018 | 80 | 0.050 |
Why?
|
| Calorimetry | 4 | 2006 | 63 | 0.050 |
Why?
|
| Hypertriglyceridemia | 1 | 2005 | 117 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 160 | 0.050 |
Why?
|
| Intestinal Absorption | 3 | 2002 | 170 | 0.050 |
Why?
|
| Mice | 8 | 2023 | 18172 | 0.050 |
Why?
|
| Racemethionine | 1 | 2023 | 5 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2001 | 1241 | 0.050 |
Why?
|
| Indocyanine Green | 2 | 1991 | 51 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 1364 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2006 | 566 | 0.050 |
Why?
|
| Regional Blood Flow | 3 | 2000 | 191 | 0.050 |
Why?
|
| Body Height | 2 | 2023 | 192 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 135 | 0.050 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2002 | 39 | 0.050 |
Why?
|
| Propranolol | 4 | 1991 | 110 | 0.050 |
Why?
|
| Prognosis | 3 | 2024 | 4848 | 0.050 |
Why?
|
| Mass Spectrometry | 5 | 2010 | 358 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2004 | 185 | 0.050 |
Why?
|
| Glycogen | 2 | 1999 | 51 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2013 | 1618 | 0.040 |
Why?
|
| Pyruvate Dehydrogenase Complex | 3 | 1998 | 11 | 0.040 |
Why?
|
| Amides | 1 | 1982 | 81 | 0.040 |
Why?
|
| Oxygen Consumption | 4 | 1996 | 295 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 2 | 2001 | 735 | 0.040 |
Why?
|
| Glycine Agents | 1 | 2021 | 10 | 0.040 |
Why?
|
| Injury Severity Score | 2 | 2000 | 232 | 0.040 |
Why?
|
| Arteries | 2 | 1999 | 209 | 0.040 |
Why?
|
| Cardiovascular Diseases | 2 | 2004 | 2094 | 0.040 |
Why?
|
| Vegetables | 1 | 2023 | 266 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2021 | 54 | 0.040 |
Why?
|
| Endothelium | 1 | 2021 | 59 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2005 | 169 | 0.040 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2000 | 32 | 0.040 |
Why?
|
| Anesthetics, Intravenous | 1 | 2000 | 49 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 2 | 2013 | 44 | 0.040 |
Why?
|
| Fentanyl | 1 | 2000 | 53 | 0.040 |
Why?
|
| Aspartic Acid | 4 | 1998 | 72 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 183 | 0.040 |
Why?
|
| Nutritional Status | 2 | 2018 | 298 | 0.040 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 16 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2002 | 252 | 0.040 |
Why?
|
| Gene Expression | 2 | 2019 | 1481 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2000 | 254 | 0.040 |
Why?
|
| Prothrombin Time | 1 | 1999 | 36 | 0.040 |
Why?
|
| Sheep | 1 | 2000 | 220 | 0.040 |
Why?
|
| Poaceae | 1 | 2019 | 14 | 0.040 |
Why?
|
| Eggs | 1 | 2019 | 23 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 1996 | 109 | 0.040 |
Why?
|
| Health Promotion | 1 | 2023 | 413 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 1999 | 43 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4646 | 0.040 |
Why?
|
| Follicular Phase | 1 | 2019 | 10 | 0.040 |
Why?
|
| Chickens | 1 | 2019 | 268 | 0.040 |
Why?
|
| Cumulus Cells | 1 | 2019 | 42 | 0.040 |
Why?
|
| Fibrin | 1 | 1999 | 64 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 130 | 0.040 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 36 | 0.040 |
Why?
|
| Ileum | 1 | 2019 | 109 | 0.040 |
Why?
|
| Milk | 1 | 2019 | 111 | 0.040 |
Why?
|
| Proline | 2 | 1996 | 78 | 0.030 |
Why?
|
| Adipose Tissue | 3 | 2007 | 497 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2000 | 759 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1999 | 408 | 0.030 |
Why?
|
| Hyponatremia | 1 | 1999 | 72 | 0.030 |
Why?
|
| Acetyl Coenzyme A | 1 | 1998 | 18 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2019 | 300 | 0.030 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2018 | 66 | 0.030 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 1997 | 9 | 0.030 |
Why?
|
| Respiration, Artificial | 2 | 2002 | 500 | 0.030 |
Why?
|
| Calorimetry, Indirect | 3 | 2010 | 64 | 0.030 |
Why?
|
| Milk Proteins | 1 | 1998 | 95 | 0.030 |
Why?
|
| Kidney | 5 | 2006 | 1279 | 0.030 |
Why?
|
| DNA Damage | 1 | 2021 | 509 | 0.030 |
Why?
|
| Catecholamines | 3 | 1992 | 50 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 1998 | 141 | 0.030 |
Why?
|
| United States | 1 | 2013 | 11885 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2017 | 38 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2058 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1999 | 177 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 2 | 1994 | 126 | 0.030 |
Why?
|
| Puberty | 1 | 1997 | 93 | 0.030 |
Why?
|
| Purines | 2 | 2013 | 115 | 0.030 |
Why?
|
| Citric Acid Cycle | 2 | 2012 | 44 | 0.030 |
Why?
|
| Food, Fortified | 1 | 2017 | 63 | 0.030 |
Why?
|
| Chemistry | 2 | 1990 | 24 | 0.030 |
Why?
|
| Chemical Phenomena | 2 | 1990 | 46 | 0.030 |
Why?
|
| Ribonucleosides | 1 | 1996 | 15 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 1374 | 0.030 |
Why?
|
| Rats | 4 | 1996 | 3378 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2001 | 997 | 0.030 |
Why?
|
| Hemostasis | 1 | 1996 | 76 | 0.030 |
Why?
|
| Hospitalization | 1 | 2005 | 1934 | 0.030 |
Why?
|
| Nucleotides | 1 | 1996 | 88 | 0.030 |
Why?
|
| Acidosis, Lactic | 1 | 1996 | 30 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 1996 | 66 | 0.030 |
Why?
|
| Glycoproteins | 1 | 1998 | 344 | 0.030 |
Why?
|
| Hypolipidemic Agents | 2 | 2010 | 195 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2024 | 6403 | 0.030 |
Why?
|
| Erythrocyte Count | 1 | 1995 | 23 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 331 | 0.030 |
Why?
|
| Hematocrit | 1 | 1995 | 104 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 2329 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 1994 | 19 | 0.030 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 1994 | 19 | 0.030 |
Why?
|
| Esterification | 2 | 2006 | 13 | 0.030 |
Why?
|
| Carbon Radioisotopes | 2 | 1998 | 62 | 0.030 |
Why?
|
| Metabolism | 1 | 1994 | 45 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2013 | 54 | 0.030 |
Why?
|
| Algorithms | 2 | 2012 | 1661 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2013 | 54 | 0.030 |
Why?
|
| Sildenafil Citrate | 1 | 2013 | 56 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1209 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2013 | 88 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2013 | 90 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 290 | 0.020 |
Why?
|
| Adipocytes | 2 | 2006 | 178 | 0.020 |
Why?
|
| Acidosis | 1 | 1994 | 97 | 0.020 |
Why?
|
| Mice, Inbred ICR | 3 | 1998 | 137 | 0.020 |
Why?
|
| Skin | 1 | 1996 | 539 | 0.020 |
Why?
|
| RNA | 1 | 1996 | 511 | 0.020 |
Why?
|
| Fetus | 1 | 1996 | 567 | 0.020 |
Why?
|
| Placenta | 1 | 2017 | 497 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 724 | 0.020 |
Why?
|
| Niacin | 1 | 1992 | 59 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2011 | 26 | 0.020 |
Why?
|
| Substrate Cycling | 1 | 1990 | 1 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2010 | 53 | 0.020 |
Why?
|
| Bradykinin | 1 | 1990 | 42 | 0.020 |
Why?
|
| Sodium Bicarbonate | 2 | 2002 | 55 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2013 | 348 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1990 | 63 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 192 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2323 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6768 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 1989 | 65 | 0.020 |
Why?
|
| Genotype | 2 | 2009 | 2588 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 4032 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2009 | 93 | 0.020 |
Why?
|
| Portal Vein | 2 | 1999 | 84 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1485 | 0.020 |
Why?
|
| Enzyme Precursors | 2 | 1998 | 22 | 0.020 |
Why?
|
| Ammonium Chloride | 1 | 1988 | 9 | 0.020 |
Why?
|
| Hemodynamics | 2 | 1991 | 810 | 0.020 |
Why?
|
| Glutamates | 1 | 1988 | 52 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 1997 | 323 | 0.020 |
Why?
|
| Vitamin A | 1 | 2007 | 57 | 0.020 |
Why?
|
| Threonine | 2 | 1998 | 62 | 0.020 |
Why?
|
| Catheterization | 1 | 2008 | 225 | 0.020 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 13 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 263 | 0.010 |
Why?
|
| Chylomicrons | 1 | 2005 | 10 | 0.010 |
Why?
|
| Lysosomes | 1 | 1987 | 264 | 0.010 |
Why?
|
| Lactic Acid | 2 | 1999 | 146 | 0.010 |
Why?
|
| Syndrome | 2 | 2002 | 1157 | 0.010 |
Why?
|
| Oxygen | 3 | 1996 | 549 | 0.010 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2004 | 5 | 0.010 |
Why?
|
| Hyperargininemia | 1 | 2004 | 13 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2005 | 303 | 0.010 |
Why?
|
| Exercise | 1 | 1990 | 866 | 0.010 |
Why?
|
| Iron | 1 | 2007 | 306 | 0.010 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2004 | 53 | 0.010 |
Why?
|
| Autophagy | 1 | 1987 | 419 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 212 | 0.010 |
Why?
|
| Plasma | 1 | 2004 | 102 | 0.010 |
Why?
|
| Weight Loss | 1 | 2007 | 534 | 0.010 |
Why?
|
| Viral Load | 1 | 2005 | 411 | 0.010 |
Why?
|
| Research Design | 1 | 1987 | 711 | 0.010 |
Why?
|
| Body Constitution | 1 | 2002 | 42 | 0.010 |
Why?
|
| HIV | 1 | 2004 | 174 | 0.010 |
Why?
|
| Lactase | 1 | 2002 | 42 | 0.010 |
Why?
|
| Choline Deficiency | 1 | 1982 | 4 | 0.010 |
Why?
|
| Africa | 1 | 2002 | 137 | 0.010 |
Why?
|
| Asia | 1 | 2002 | 125 | 0.010 |
Why?
|
| Latin America | 1 | 2002 | 108 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1982 | 97 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 421 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1982 | 111 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 133 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1998 | 2553 | 0.010 |
Why?
|
| Respiration | 2 | 1992 | 117 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 408 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 4656 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2002 | 234 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 3814 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2002 | 294 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2000 | 99 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1999 | 82 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2002 | 357 | 0.010 |
Why?
|
| Muscle Development | 1 | 2000 | 72 | 0.010 |
Why?
|
| Potassium | 2 | 1991 | 263 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 1583 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2002 | 902 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 594 | 0.010 |
Why?
|
| Risk Factors | 2 | 2004 | 10953 | 0.010 |
Why?
|
| Mathematics | 1 | 1998 | 71 | 0.010 |
Why?
|
| Mexican Americans | 1 | 1999 | 162 | 0.010 |
Why?
|
| Oxaloacetates | 1 | 1998 | 2 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 1998 | 3 | 0.010 |
Why?
|
| Portal System | 1 | 1997 | 35 | 0.010 |
Why?
|
| Intestines | 1 | 1982 | 587 | 0.010 |
Why?
|
| Dimerization | 1 | 1998 | 137 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 1997 | 20 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 1215 | 0.010 |
Why?
|
| Methylhistidines | 2 | 1990 | 7 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 1997 | 43 | 0.010 |
Why?
|
| Linear Models | 1 | 1999 | 684 | 0.010 |
Why?
|
| Heart Rate | 2 | 1992 | 573 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1991 | 1317 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1997 | 234 | 0.010 |
Why?
|
| Prevalence | 1 | 2004 | 2685 | 0.010 |
Why?
|
| Palliative Care | 1 | 2001 | 448 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1996 | 101 | 0.010 |
Why?
|
| APACHE | 1 | 1996 | 55 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 252 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1996 | 147 | 0.010 |
Why?
|
| Cyanobacteria | 1 | 1995 | 9 | 0.010 |
Why?
|
| Parenteral Nutrition Solutions | 1 | 1995 | 5 | 0.010 |
Why?
|
| Solutions | 1 | 1995 | 50 | 0.010 |
Why?
|
| Electrolytes | 1 | 1995 | 59 | 0.010 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 1996 | 99 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1997 | 360 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1996 | 576 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 3680 | 0.010 |
Why?
|
| Calcium Chloride | 1 | 1994 | 23 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 254 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1996 | 929 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 1997 | 492 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 1996 | 194 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 2896 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 1110 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1992 | 31 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1996 | 454 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1988 | 1340 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1995 | 814 | 0.010 |
Why?
|
| Protein Binding | 1 | 1996 | 1650 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1992 | 56 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1992 | 185 | 0.010 |
Why?
|
| Absorption | 1 | 1991 | 49 | 0.010 |
Why?
|
| Basal Metabolism | 1 | 1991 | 93 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 2390 | 0.010 |
Why?
|
| Placebos | 1 | 1991 | 223 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1991 | 153 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 3463 | 0.000 |
Why?
|
| Phenotype | 1 | 2000 | 4464 | 0.000 |
Why?
|
| Bed Rest | 1 | 1989 | 25 | 0.000 |
Why?
|
| Insulin Infusion Systems | 1 | 1989 | 67 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 3407 | 0.000 |
Why?
|
| Wound Healing | 1 | 1992 | 486 | 0.000 |
Why?
|
| Body Temperature Regulation | 1 | 1987 | 53 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1987 | 79 | 0.000 |
Why?
|
| Glucocorticoids | 1 | 1989 | 347 | 0.000 |
Why?
|
| Heart | 1 | 1991 | 659 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1988 | 534 | 0.000 |
Why?
|